BEAM - Beam Therapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

BEAM is currently covered by 13 analysts with an average price target of $46.08. This is a potential upside of $26.2 (131.79%) from yesterday's end of day stock price of $19.88.

Beam Therapeutics 's activity chart (see below) currently has 67 price targets and 80 ratings on display. The stock rating distribution of BEAM is 63.41% BUY and 36.59% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 36.41% with an average time for these price targets to be met of 70.79 days.

Highest price target for BEAM is $80, Lowest price target is $21, average price target is $50.27.

Most recent stock forecast was given by GENA WANG from BARCLAYS on 06-Aug-2025. First documented stock forecast 02-Mar-2020.

Currently out of the existing stock ratings of BEAM, 26 are a BUY (63.41%), 15 are a HOLD (36.59%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$21

$0.12 (0.57%)

$25

1 months 4 days ago
(06-Aug-2025)

9/11 (81.82%)

$2.7 (14.75%)

158

Buy

$55

$34.12 (163.41%)

$78

4 months 3 days ago
(07-May-2025)

0/4 (0%)

$38.77 (238.88%)

Buy

$70

$49.12 (235.25%)

$105

4 months 3 days ago
(07-May-2025)

0/3 (0%)

$53.77 (331.30%)

Buy

$80

$59.12 (283.14%)

$80

5 months 3 days ago
(07-Apr-2025)

0/8 (0%)

$64.7 (422.88%)

Buy

5 months 29 days ago
(12-Mar-2025)

1/10 (10%)

$12.38 (46.51%)

118

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is BEAM (Beam Therapeutics ) average time for price targets to be met?

On average it took 70.79 days on average for the stock forecasts to be realized with a an average price target met ratio 36.41

Which analyst has the current highest performing score on BEAM (Beam Therapeutics ) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on BEAM (Beam Therapeutics )?

David Nierengarten works at WEDBUSH and has 8 price targets and 7 ratings on BEAM

Which analyst is the currently most bullish on BEAM (Beam Therapeutics )?

Patrick Trucchio with highest potential upside - $59.12

Which analyst is the currently most reserved on BEAM (Beam Therapeutics )?

Rick Bienkowski with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?